Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types

Cancer Genetics and Cytogenetics

Volumn 129, Issue 2, 2001, Pages 93-101

  Gursky, Susan ^a   Olopade, Olufunmilayo I ^a   Rowley, Janet D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA FRAGMENT; PROTEIN; PROTEIN ALA; PROTEIN CDKN2A; PROTEIN MTAP; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CANCER CELL CULTURE; CANCER TISSUE; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ARM; CHROMOSOME BAND; CHROMOSOME DELETION; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE ISOLATION; GENE MAPPING; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; LEUKEMIA; LUNG CARCINOMA; MELANOMA; MUTATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RNA SPLICING; SEQUENCE HOMOLOGY;

EID: 0034830528     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00444-7     Document Type: Article

References (35)

1. Homozygous deletion of the a- and β1-interferon genes in human leukemia and derived cell lines
2. P16 alterations and deletion mapping of 9p21-22 in malignant mesothelioma
3. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas
4. Homozygous deletions within chromosome bands 9p21-22 in bladder cancer
5. Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia
6. A cell cycle regulator potentially involved in genesis of many tumor types
7. Allelic loss of 9p21 and mutations of the CDKN2B/p16 gene develop as early lesion during neoplastic progression in Barrett's esophagus
8. Chromosome 9p allelic loss and p16/CDKN2B in breast cancer and evidence of p16 inactivation in immortal epithelial cells
9. LOH and mutational analysis of CDKN2B in primary human ovarian cancer
10. Mutational analysis of CDKN2B/MTS1/p16ink4 in human breast carcinomas
11. Alterations of the p15, p16, and p18 genes in osteosarcoma
12. Homozygous deletions and loss of expression of the CDKN2B gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors
13. Contribution of chromosome 9p21-22 deletion to the progression of human renal cell carcinoma
14. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene
15. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma
16. Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: Evidence for two deleted regions
17. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: The deleted region involves markers outside of the MTS1 and MTS2 genes
18. Retention of the CDKN2BA locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma
19. The selective isolation of cDNAs encoded by the region surrounding the human interleukin 4 and 5 genes
20. A method for the rapid sequence-independent amplification of microdissected chromosomal material
21. Detection of CDKN2B deletions in tumor cells and primary gliomas by interphase fluorescence in situ hybridization
22. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
23. ARF
24. INK4a/CDKN2A tumor suppressor and its relatives
25. Tumor surveillance via the ARF-p53 pathway
26. Frequency of homozygous deletion at p16/CDKN2B in primary human tumours
27. Construction of a 2.8 megabase YAC contig and cloning of the methylthioadenosine phosphorylase (MTAP) gene from the tumor suppressor locus on 9p21
28. 5′-deoxy-5′-methylthioadenosine phosphorylase - II. Role of the enzyme in the metabolism and antineoplastic action of adenine-substituted analogs of 5′-deoxy-5′-methylthioadenosine
29. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines
30. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
31. Molecules in focus NM23-NDP-kinase
32. Delineation of multiple deleted regions in 7q in myeloid disorders
33. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia